Genome Biologics Company

Genome Biologics identifies novel tissue-specific RNAi therapies targeting the transcriptome of cardiovascular and cardiometabolic disease
Technology: Biotechnology, Genetics, Pharmaceutical, Therapeutics
Industry: Early Drug Development
Headquarters: Hessen, Sachsen-Anhalt, Germany
Founded Date: 2017-01-01
Employees Number: 11-50
Investors Number: 1
Total Funding: 2470000
Last Funding Date: 2018-09-01
Last Funding Type: Grant

Visit Website
info@genomebiologics.com
https://twitter.com/genomebiologics
Register and Claim Ownership